Japan approves Shionogi’s Covid antiviral under new emergency approval pathway
Japanese regulators on Tuesday signed off on Shionogi’s domestic Covid-19 antiviral drug, known as Xocova
Merck’s Massive € 290 Million Investment in U.S. Drug Safety Testing is a Win for Consumers.
Responds to growing global demand for biosafety testing aan s essential requirement for drug development
Sensorium Achieves Major Milestone with $30M to Change Risk-Value Proposition in CNS Drug Discovery
Human-first Biodynamic Discovery Platform™ employs cutting-edge chemistry, neuroscience, and machine learning to advance plant- and
New CFO Richard Peterson to Help Lead “Turn Biotechnologies” into the Future
– Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions,
Sanofi and BioMed X Team Up to Use AI for Drug Development.
HEIDELBERG, Germany — BioMed X announced today the launch of their first joint research project with
Prime Medicine makes a splash in the biotech world with a record-breaking IPO
CAMBRIDGE, Mass.-Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class
Gene therapy with equitable access can have a massive impact on global health.
Low and Middle-Income Countries(LMIC’s) can and must play a leading role in determining the future
Merck pays $250 million to Moderna to license the joint development of a cancer vaccine.
Merck and Moderna have been collaborating on cancer vaccine research for the past six years,
Vertex moves forward with research of a second-generation rare disease drug.
– Initiates first-in-human trial of next-wave AAT corrector, VX-634 – – Phase 2 study evaluating the impact